RT-qPCR was used to assess the expression of known urinary PCa markers (e.g. PSA, PCA3), a panel of 8 genes of interest to our group and promising new PCa markers previously reported in urine (e.g. SPINK1, PSCA, CD24, survivin). This evidence concerns the gene CD24 and posterior cortical atrophy.